Fabian Lang

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 551 citations · Full text

Medicine, Hematology, Oncology +15

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 467 citations · Full text

Medicine, Oncology, Pharmacology +9

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Andrea Kaifie, Martin Kirschner, Dominik Wolf‎ et al. · Journal of Hematology & Oncology · 2016 · 184 citations · Full text

Medicine, Hematology, Internal Medicine +17

Sorafenib As Maintenance Therapy Post Allogeneic Stem Cell Transplantation for FLT3-ITD Positive AML: Results from the Randomized, Double-Blind, Placebo-Controlled Multicentre Sormain Trial

Andreas Burchert, Gesine Bug, Jürgen Finke et al. · Blood · 2018 · 104 citations

Medicine, Hematology, Oncology +10

Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation

Katharina Raum, Sandra Marković, Verena Nowak et al. · Blood · 2018 · 77 citations · Full text

Medicine, Genetics, Molecular Genetics +11